Rulonilimab
Product Specifications
CAS Number
2417124-95-7
Target
PD-1/PD-L1
Related Pathways
Cell Cycle/Checkpoint|||Apoptosis|||Immunology/Inflammation
Bioactivity
Rulonilimab, a human IgG1 monoclonal antibody, targets and binds to PD-1, inhibiting its downstream signaling pathways. This action potentially enables immune checkpoint inhibition and exhibits anti-tumor activity [1].
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6489588-01 0.1 mL
NEK2 (Never in Mitosis A-related Kinase 2, NimA-related Protein Kinase 2, NEK2A, HSPK 21, HsPK21, NimA-like Protein Kinase 1, NLK1, Serine/threonine Protein Kinase Nek2) (MaxLight 405)
Ask
View Details 
MBS6489588-02 5x 0.1 mL
NEK2 (Never in Mitosis A-related Kinase 2, NimA-related Protein Kinase 2, NEK2A, HSPK 21, HsPK21, NimA-like Protein Kinase 1, NLK1, Serine/threonine Protein Kinase Nek2) (MaxLight 405)
Ask
View Details GTR15175554 1 Vial
Lentiviral mouse Sptlc1 shRNA (UAS) - Lentiviral mouse Sptlc1 shRNA (UAS) (100)
Ask
View Details